- Home
- INO vs CXE Comparison
INO vs CXE Comparison
Compare INO & CXE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | INO | CXE |
|---|---|---|
| Founded | 1979 | 1989 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 116.1M | 118.1M |
| IPO Year | 1998 | N/A |
Fundamental Metrics
Financial Performance| Metric | INO | CXE |
|---|---|---|
| Price | $1.56 | $3.72 |
| Analyst Decision | Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $9.00 | N/A |
| AVG Volume (30 Days) | ★ 1.9M | 62.9K |
| Earning Date | 11-10-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 4.36% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.07 |
| Revenue | ★ $182,337.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $23,060.18 | N/A |
| P/E Ratio | ★ N/A | $51.00 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.30 | $2.95 |
| 52 Week High | $2.98 | $3.67 |
Technical Indicators
Market Signals| Indicator | INO | CXE |
|---|---|---|
| Relative Strength Index (RSI) | 38.02 | 45.55 |
| Support Level | $1.47 | $3.63 |
| Resistance Level | $1.70 | $3.78 |
| Average True Range (ATR) | 0.10 | 0.03 |
| MACD | -0.01 | -0.00 |
| Stochastic Oscillator | 26.15 | 27.78 |
Price Performance
Historical ComparisonAbout INO Inovio Pharmaceuticals Inc.
Inovio Pharmaceuticals Inc is a United States-based biotechnology company. The company is focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
About CXE MFS High Income Municipal Trust
Mfs High Income Municipal Trust is a United States-based diversified closed-end management investment company. Its investment objective is to seek high current income exempt from federal income tax. The fund invests a majority of its net assets, including assets attributable to preferred shares and borrowings for investment purposes, in tax-exempt bonds and tax-exempt notes.